Author:
Beall Reed F.,Darrow Jonathan J.,Kesselheim Aaron S.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference38 articles.
1. 1. Kaplan, S. , "F.D.A. Approves Gen-eric EpiPen that May Be Cheaper," New York Times, August 16, 2018, available at (last visited February 22, 2019)
2. C.V. Dave, A.S. Kesselheim, E.R. Fox, P. Qiu, A. Hartzema, "High Generic Drug Prices and Market Competition: A Retrospective Cohort Study," Annals of Internal Medicine 167, no. 3 (2017): 145-151
3. A.S. Kesselheim, J. Avorn, A. Sarpatwari, "The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform," JAMA 316, no. 8 (2016): 858-871.
4. Prevalence and Predictors of Generic Drug Skepticism Among Physicians
5. 28. Patents and Exclusivity, supra note 12.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献